Methods of using OSK1 peptide analogs
US7825093B2 · kind B2 · utility
3Cited by
89References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2007 |
| Grant date | Nov 2, 2010 |
| Priority date | — |
| Expiry date | Mar 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.